Jason Waechter1, Anand Kumar, Stephen E Lapinsky, John Marshall, Peter Dodek, Yaseen Arabi, Joseph E Parrillo, R Phillip Dellinger, Allan Garland. 1. 1Department of Critical Care, University of Calgary, Calgary, AB, Canada. 2Department of Medicine, University of Manitoba, Winnipeg, MB, Canada. 3Department of Medicine, University of Toronto, Toronto, ON, Canada. 4Center for Health Evaluation and Division of Critical Care Medicine, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada. 5Department of Intensive Care, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. 6Department of Medicine, Hackensack University Medical Center, Hackensack, NJ. 7Department of Medicine, Cooper Medical School of Rowan University, Camden, NJ.
Abstract
OBJECTIVE: Fluids and vasoactive agents are both used to treat septic shock, but little is known about how they interact or the optimal way to administer them. We sought to determine how hospital mortality was influenced by combined use of these two treatments. DESIGN: Retrospective evaluation using multivariable logistic regression to evaluate the association between hospital mortality and categorical variables representing initiation of vasoactive agents and volumes of IV fluids given 0-1, 1-6, and 6-24 hours after onset, including interactions and adjusting for potential confounders. SETTING: ICUs of 24 hospitals in 3 countries. PATIENTS: Two thousand eight hundred forty-nine patients who survived more than 24 hours after after onset of septic shock, admitted between 1989 and 2007. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Fluids and vasoactive agents had strong, interacting associations with mortality (p < 0.0001). Mortality was lowest when vasoactive agents were begun 1-6 hours after onset, with more than 1 L of fluids in the initial hour after shock onset, more than 2.4 L from hours 1-6, and 1.6-3.5 L from 6 to 24 hours. The lowest mortality rates were associated with starting vasoactive agents 1-6 hours after onset. CONCLUSIONS: The focus during the first hour of resuscitation for septic shock should be aggressive fluid administration, only thereafter starting vasoactive agents, while continuing aggressive fluid administration. Starting vasoactive agents in the initial hour may be detrimental, and not all of that association is due to less fluids being given with such early initiation of vasoactive agents.
OBJECTIVE: Fluids and vasoactive agents are both used to treat septic shock, but little is known about how they interact or the optimal way to administer them. We sought to determine how hospital mortality was influenced by combined use of these two treatments. DESIGN: Retrospective evaluation using multivariable logistic regression to evaluate the association between hospital mortality and categorical variables representing initiation of vasoactive agents and volumes of IV fluids given 0-1, 1-6, and 6-24 hours after onset, including interactions and adjusting for potential confounders. SETTING: ICUs of 24 hospitals in 3 countries. PATIENTS: Two thousand eight hundred forty-nine patients who survived more than 24 hours after after onset of septic shock, admitted between 1989 and 2007. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Fluids and vasoactive agents had strong, interacting associations with mortality (p < 0.0001). Mortality was lowest when vasoactive agents were begun 1-6 hours after onset, with more than 1 L of fluids in the initial hour after shock onset, more than 2.4 L from hours 1-6, and 1.6-3.5 L from 6 to 24 hours. The lowest mortality rates were associated with starting vasoactive agents 1-6 hours after onset. CONCLUSIONS: The focus during the first hour of resuscitation for septic shock should be aggressive fluid administration, only thereafter starting vasoactive agents, while continuing aggressive fluid administration. Starting vasoactive agents in the initial hour may be detrimental, and not all of that association is due to less fluids being given with such early initiation of vasoactive agents.
Authors: Xuefeng Peng; Yi Ding; David Wihl; Omer Gottesman; Matthieu Komorowski; Li-Wei H Lehman; Andrew Ross; Aldo Faisal; Finale Doshi-Velez Journal: AMIA Annu Symp Proc Date: 2018-12-05
Authors: Robert A Balk; Sameer S Kadri; Zhun Cao; Scott B Robinson; Craig Lipkin; Samuel A Bozzette Journal: Chest Date: 2016-08-25 Impact factor: 9.410
Authors: Stephen P J Macdonald; Gerben Keijzers; David McD Taylor; Frances Kinnear; Glenn Arendts; Daniel M Fatovich; Rinaldo Bellomo; David McCutcheon; John F Fraser; Juan-Carlos Ascencio-Lane; Sally Burrows; Edward Litton; Amanda Harley; Matthew Anstey; Ashes Mukherjee Journal: Intensive Care Med Date: 2018-10-31 Impact factor: 17.440